RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy

被引:2
作者
Cheng, Fang [1 ]
He, Song [2 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Lab Anim Ctr, Xian 710061, Peoples R China
[2] Chongqing Med Univ, Mol Med & Tumor Res Ctr, Chongqing 400016, Peoples R China
关键词
RNA interference (RNAi); Dendritic cells (DCs); siRNA; shRNA; Immunotherapy; Specific immune responses; Vaccine; WISKOTT-ALDRICH-SYNDROME; DC-SIGN; CHEMICAL-MODIFICATION; DOWN-REGULATION; IMMUNE-SYSTEM; GENE-THERAPY; IN-VITRO; SIRNA; EXPRESSION; ANTIGEN;
D O I
10.1007/s11033-009-9789-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA interference (RNAi) is a natural process by which small interfering RNA duplex directs sequencespecific post-transcriptional silencing of homologous genes by binding to its complementary mRNA and triggering its elimination. The history of RNAi has only about two decades, however, further studies have revealed that it is a potent method of gene silencing that has developed rapidly over the past few years as a result of its extensive importance in the study of genetics, molecular biology and physiology. RNAi technology has also recently yielded significant insight into dendritic cells (DCs) by helping to elucidate numerous mechanisms that regulate the development, activation and function of cells that mediate immunity. In addition, because of its ability to suppress gene expression effectively, this technique may be used to regulate the immune response for clinical purposes. As the key antigen presenting cells, DCs play a crucial part in the start of an immune response and in the enhancement and regulation of cell mediated immune reactions. The current studies indicated that targeting DCs with RNAi is a novel and effective therapeutic method for the fundamental research, and displayed great potential in clinical treatment.
引用
收藏
页码:2635 / 2644
页数:10
相关论文
共 50 条
  • [41] In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer
    Lee, Hyun Ju
    Hong, Cheol Yi
    Kim, Mi-Hyun
    Lee, Youn-Kyung
    Thanh-Nhan Nguyen-Pham
    Park, Byoung Chul
    Yang, Deok-Hwan
    Chung, Ik-Joo
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (01) : 60 - 67
  • [42] Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?
    Huang, Xiuyi
    Liu, Yunchong
    Li, Zilun
    Lerman, Lilach O.
    STEM CELLS, 2023, 41 (10) : 893 - 906
  • [43] Tumor vaccine therapy against recrudescent tumor using dendritic cells simultaneously transfected with tumor RNA and granulocyte macrophage colony-stimulating factor RNA
    Naka, Teiji
    Iwahashi, Makoto
    Nakamura, Masaki
    Ojima, Toshiyasu
    Nakamori, Mikihito
    Ueda, Kentaro
    Katsuda, Masahiro
    Miyazawa, Motoki
    Ishida, Koichiro
    Yamaue, Hiroki
    CANCER SCIENCE, 2008, 99 (02) : 407 - 413
  • [44] Status and potential of gene therapy in clinical medicine - Assessment of an emerging health technology through systematic survey of clinical gene therapy protocols and published results
    Lyngstadaas, A
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 645 - 674
  • [45] HIV Infection Affects Blood Myeloid Dendritic Cells after Successful Therapy and despite Nonprogressing Clinical Disease
    Fontaine, Julie
    Coutlee, Francois
    Tremblay, Cecile
    Routy, Jean-Pierre
    Poudrier, Johanne
    Roger, Michel
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) : 1007 - 1018
  • [46] Potential clinical applications of placental stem cells for use in fetal therapy of birth defects
    Vanover, Melissa
    Wang, Aijun
    Farmer, Diana
    PLACENTA, 2017, 59 : 107 - 112
  • [47] Molecular aspects of ischemic heart disease: Ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy
    Nordlie, MA
    Wold, LE
    Simkhovich, BZ
    Sesti, C
    Kloner, RA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (01) : 17 - 30
  • [48] Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use
    Bernard, J
    Ittelet, D
    Christoph, A
    Potron, G
    Adjizian, JC
    Kochman, S
    Lopez, M
    HEMATOLOGY AND CELL THERAPY, 1998, 40 (01): : 17 - 26
  • [49] Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells
    Rossowska, Joanna
    Anger, Natalia
    Szczygiel, Agnieszka
    Mierzejewska, Jagoda
    Pajtasz-Piasecka, Elzbieta
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [50] Effects of interleukin-1 receptor-associated kinase 1 RNA interference in dendritic cells on inflammatory cytokine release and T-cell proliferation
    Gao, Yan
    Xu, Xuxu
    Feng, Juan
    Ma, Ying
    Zheng, Dongming
    Meng, Yiming
    Shan, Fengping
    MOLECULAR MEDICINE REPORTS, 2016, 14 (06) : 5685 - 5692